Alpha Tau Medical (NASDAQ:DRTSW) Trading 10.7% Higher

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) shot up 10.7% on Thursday . The company traded as high as $0.23 and last traded at $0.23. 1,200 shares changed hands during trading, a decline of 84% from the average session volume of 7,663 shares. The stock had previously closed at $0.21.

Alpha Tau Medical Stock Performance

The stock has a 50 day simple moving average of $0.26 and a two-hundred day simple moving average of $0.26.

Hedge Funds Weigh In On Alpha Tau Medical

Large investors have recently modified their holdings of the business. Polar Asset Management Partners Inc. acquired a new position in Alpha Tau Medical during the 1st quarter worth about $134,000. Walleye Capital LLC acquired a new position in Alpha Tau Medical during the 1st quarter worth about $112,000. Chicago Partners Investment Group LLC acquired a new position in Alpha Tau Medical during the 1st quarter worth about $55,000. Walleye Trading LLC acquired a new position in Alpha Tau Medical during the 1st quarter worth about $65,000. Finally, Jane Street Group LLC acquired a new position in Alpha Tau Medical during the 1st quarter worth about $64,000.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.